About
Image-based Biomarker Detection
Areas of Focus
Categories
DiagnosticsAI FocusedSoutheastern U.S.
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
5
As Collaborator
0
Total Enrollment
541
By Phase
PHASE2: 3PHASE3: 2
By Status
COMPLETED: 3TERMINATED: 2
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
Today
Hover over trial bars to see details
Recent Trials
NCT00861185Lead Sponsor
Study to Assess Safety and Efficacy of Oral Senicapoc Administration on Exercise-induced Asthma
PHASE2Completed
69 participants
Started: Mar 31, 2009 · Completed: Sep 30, 2009
NCT00861211Lead Sponsor
Safety and Efficacy Study of Oral Senicapoc on Allergen Challenge in Atopic Asthmatic Subjects
PHASE2Completed
34 participants
Started: Oct 31, 2008 · Completed: May 31, 2009
NCT00294541Lead Sponsor
A Study Evaluating the Long-Term Safety of ICA-17043 in Sickle Cell Disease Patients With or Without Hydroxyurea Therapy
PHASE3Terminated
51 participants
Started: Feb 28, 2006 · Completed: Jun 30, 2007
NCT00102791Lead Sponsor
A Stratified Sickle Event Randomized Trial (ASSERT)
PHASE3Terminated
297 participants
Started: Feb 28, 2005 · Completed: Jun 30, 2007
NCT00040677Lead Sponsor
A Study of the Efficacy and Safety of ICA-17043 (With or Without Hydroxyurea) in Patients With Sickle Cell Anemia.
PHASE2Completed
90 participants
Started: Feb 28, 2002 · Completed: Jan 31, 2004
Locations (1)
Headquarters
Miami, FL, United States
Map
Loading map...